Office of Research Message from the Vice Deans of Research Leadership & Staff Clinical Trials Administration Research Support & Development Biostatistical Resources Grant Support & Review Services NIH K and F Submissions Guide Training Grant Support NIH Resubmission Program NIH Resources NIH Boot Camp Physician Scientist Resources Guidance for Proposal Submissions Grant Incentive Programs and Pilot Awards Researcher Pipeline Policies and Guidelines Environmental Health and Safety Human Research Foreign Affiliations School Center Guidelines Space Allocation Vendor Event Policy Responsible Conduct of Research Rigor and Responsibility COVID-19 Response Funding Opportunities School of Medicine Funding Search Tool Faculty Research Retreat School of Medicine Funding Search Tool Home Research Office of Research School of Medicine Funding Search Tool Below is a curated, searchable and filterable list of funding opportunities announced by NIH in their weekly NIH guide LISTSERV. This list reflects funding opportunities pertinent to many UCI researchers. Using filters may reduce your results, so use judiciously. Opportunities are added weekly. You can sign up for the NIH guide listserv to receive a comprehensive list of funding opportunities every Friday. NIH Guide Listserv Search Funding Discipline - Any -Acute/Chronic PainAgingAlcoholism, Alcohol UseAlzheimer's/DementiaAmyotrophic lateral sclerosis (ALS)Artificial Intelligence/Machine LearningAutoimmune/ImmunologyBehavioral and Social ScienceBiomedical ImagingBiomedical TechnologyBrain DisordersCancerCancer GenomicsCannabinoid/CannabidiodCardiology/VascularCaregiving ResearchChronic ConditionsClimate ChangeClinical TrialsClinical/DiagnosticCoronaviruses/COVIDData Science/Software/DatabasesDiabetesDigestive/KidneyDissemination and Implementation ResearchDown SyndromeEarly career research awardEating DisordersEmergency CareEnvironmental healthEpilepsyEye Disease and Disorders of VisionFood AllergiesGene TherapyGenetic TestingGynecologyHealth Disparities/Social determinantsHealthcare deliveryHearing LossHematologyHIV/AIDSHuman GenomeHuntington's DiseaseInfectious Diseases/MicrobiologyLung/RespiratoryMedical EducationMental Health/IllnessMicrobiomeMusculoskeletal/SkinN/ANeurology/NeurodegenerativenoneNutritionObesityOrthopedicOtolaryngology-Head & Neck SurgeryPathologyPatient Care/SafetyPediatricPhysical ActivityPhysical RehabilitationPneumonia & InfluenzaPost-Traumatic Stress Disorder (PTSD)Precision MedicinePregnancy/Maternal Health/ObstetricsRadiation OncologyRare DiseasesRegenerative MedicineSepsisSickle Cell DiseaseSleepSpinal Cord InjuryStem Cell ResearchStrokeSubstance Abuse/AddictionSuicideSurgeryTelehealthTransplantationTraumatic Brain Injury (TBI)UrologyVaccine RelatedVector-Borne DiseasesViolenceWomenWound Healing and Care Date Range Min Max 2024 Deadline 3: Oct 16, 2024 Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional) (PAR-23-152) This Notice of Funding Opportunity (NOFO) aims to support innovative research relevant to advancing the understanding of the effects of climate change across the cancer control continuum, from cancer etiology and cancer risks through survivorship, and ways to prevent or mitigate negative health effects. National Institutes of Health (NIH) Federal Cancer Healthcare delivery Climate Change 2024 Deadline 3: Oct 16, 2024 Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional) (PAR-23-179) This Small Research Grant (R03) program will support meritorious projects to provide needed scientific insight to improve the prevention, diagnosis, treatment, and/or care for individuals with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). National Institutes of Health (NIH) Federal Aging Neurology/Neurodegenerative Early career research award 2024 Deadline 3: Oct 16, 2024 Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) (PAR-23-208) The goal of this Notice of Funding Opportunity (NOFO) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD). National Institutes of Health (NIH) Federal Neurology/Neurodegenerative Alzheimer's/Dementia Mental Health/Illness 2024 Deadline 3: Oct 16, 2024 Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) (PAR-24-025) This Notice of Funding Opportunity (NOFO) encourages research on the biology of high confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular and circuit substrates of neural function. For the purposes of this NOFO , the term “complex” can refer to a multifactorial contribution to risk (e.g., polygenic and/or environmental) and/or highly distributed functional features of the brain disorder. National Institutes of Health (NIH) Federal Brain Disorders Neurology/Neurodegenerative 2024 Deadline 3: Oct 16, 2024 PAR-23-255: Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). National Institutes of Health (NIH) Federal Cancer Cancer Genomics Data Science/Software/Databases 2024 Deadline 3: Oct 16, 2024 Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) (PAR-23-301) The goal of this NOFO is to support applications for novel theory and methods development that enable better understanding of how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should account for interdependencies across scales of biological, social, and ecological organization, make extensive use of theory, modeling, and validation with available large-scale datasets, and may be interdisciplinary drawing from the natural and social sciences. National Institutes of Health (NIH) Federal Human Genome 2024 Deadline 2: Oct 16, 2024 New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional) (PAR-24-161) The purpose of this funding opportunity is to encourage multidisciplinary investigators to develop exploratory, highly novel new approaches, or innovative applications of existing approaches, to measure brain activity, connectivity, genomics, or other aspects across the age spectrum of neurodevelopment. National Institutes of Health (NIH) Federal Neurology/Neurodegenerative Aging Cancer 2024 Deadline 2: Oct 17, 2024 HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R61/R33 Clinical Trial Optional) (RFA-DA-24-066) Despite an evidence base of effective programs to prevent the initiation of substance use, misuse and disorder, a substantial research to practice gap exists. National Institutes of Health (NIH) Federal Substance Abuse/Addiction Behavioral and Social Science 2024 Deadline 2: Oct 31, 2024 Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional) (PAR-23-145) The Maximizing Investigators' Research Award (MIRA) under this Notice of Funding Opportunity (NOFO) provides support for a program of research in an early stage investigator's laboratory that falls within the mission of NIGMS. National Institutes of Health (NIH) Federal Early career research award 2024 Deadline: Nov 01, 2024 NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) (PAR-23-242) This notice of funding opportunity (NOFO) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This NOFO is specifically targeted toward laboratory-based scientists. National Institutes of Health (NIH) Federal Cancer Cancer Genomics Pagination First page « First Previous page ‹‹ … Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Next page ›› Last page Last »
2024 Deadline 3: Oct 16, 2024 Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional) (PAR-23-152) This Notice of Funding Opportunity (NOFO) aims to support innovative research relevant to advancing the understanding of the effects of climate change across the cancer control continuum, from cancer etiology and cancer risks through survivorship, and ways to prevent or mitigate negative health effects. National Institutes of Health (NIH) Federal Cancer Healthcare delivery Climate Change
2024 Deadline 3: Oct 16, 2024 Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional) (PAR-23-179) This Small Research Grant (R03) program will support meritorious projects to provide needed scientific insight to improve the prevention, diagnosis, treatment, and/or care for individuals with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). National Institutes of Health (NIH) Federal Aging Neurology/Neurodegenerative Early career research award
2024 Deadline 3: Oct 16, 2024 Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) (PAR-23-208) The goal of this Notice of Funding Opportunity (NOFO) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD). National Institutes of Health (NIH) Federal Neurology/Neurodegenerative Alzheimer's/Dementia Mental Health/Illness
2024 Deadline 3: Oct 16, 2024 Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) (PAR-24-025) This Notice of Funding Opportunity (NOFO) encourages research on the biology of high confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular and circuit substrates of neural function. For the purposes of this NOFO , the term “complex” can refer to a multifactorial contribution to risk (e.g., polygenic and/or environmental) and/or highly distributed functional features of the brain disorder. National Institutes of Health (NIH) Federal Brain Disorders Neurology/Neurodegenerative
2024 Deadline 3: Oct 16, 2024 PAR-23-255: Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). National Institutes of Health (NIH) Federal Cancer Cancer Genomics Data Science/Software/Databases
2024 Deadline 3: Oct 16, 2024 Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) (PAR-23-301) The goal of this NOFO is to support applications for novel theory and methods development that enable better understanding of how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should account for interdependencies across scales of biological, social, and ecological organization, make extensive use of theory, modeling, and validation with available large-scale datasets, and may be interdisciplinary drawing from the natural and social sciences. National Institutes of Health (NIH) Federal Human Genome
2024 Deadline 2: Oct 16, 2024 New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional) (PAR-24-161) The purpose of this funding opportunity is to encourage multidisciplinary investigators to develop exploratory, highly novel new approaches, or innovative applications of existing approaches, to measure brain activity, connectivity, genomics, or other aspects across the age spectrum of neurodevelopment. National Institutes of Health (NIH) Federal Neurology/Neurodegenerative Aging Cancer
2024 Deadline 2: Oct 17, 2024 HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R61/R33 Clinical Trial Optional) (RFA-DA-24-066) Despite an evidence base of effective programs to prevent the initiation of substance use, misuse and disorder, a substantial research to practice gap exists. National Institutes of Health (NIH) Federal Substance Abuse/Addiction Behavioral and Social Science
2024 Deadline 2: Oct 31, 2024 Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional) (PAR-23-145) The Maximizing Investigators' Research Award (MIRA) under this Notice of Funding Opportunity (NOFO) provides support for a program of research in an early stage investigator's laboratory that falls within the mission of NIGMS. National Institutes of Health (NIH) Federal Early career research award
2024 Deadline: Nov 01, 2024 NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) (PAR-23-242) This notice of funding opportunity (NOFO) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This NOFO is specifically targeted toward laboratory-based scientists. National Institutes of Health (NIH) Federal Cancer Cancer Genomics